Pluristem Valuation
| PSTIDelisted Stock | USD 0.67 0.02 2.90% |
Pluristem is overvalued. Pluristem holds a recent Real Value of $0.64 per share. The prevailing price of the company is $0.67. Our model determines the value of Pluristem from analyzing the company fundamentals such as Shares Outstanding of 32.1 M, shares owned by institutions of 12.80 %, and Return On Equity of -86.55 as well as examining its technical indicators and probability of bankruptcy. In general, most investors support purchasing undervalued entities and trading away overvalued entities since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
Please note that Pluristem's price fluctuation is very steady at this time. Calculation of the real value of Pluristem is based on 3 months time horizon. Increasing Pluristem's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Pluristem is useful when determining the fair value of the Pluristem stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Pluristem. Since Pluristem is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Pluristem Stock. However, Pluristem's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.67 | Real 0.64 | Hype 0.67 |
The real value of Pluristem Stock, also known as its intrinsic value, is the underlying worth of Pluristem Company, which is reflected in its stock price. It is based on Pluristem's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Pluristem's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Pluristem's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Pluristem helps investors to forecast how Pluristem stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Pluristem more accurately as focusing exclusively on Pluristem's fundamentals will not take into account other important factors: Pluristem Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Pluristem's current stock value. Our valuation model uses many indicators to compare Pluristem value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pluristem competition to find correlations between indicators driving Pluristem's intrinsic value. More Info.Pluristem is considered to be number one stock in price to earning category among related companies. It is considered to be number one stock in price to book category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Pluristem by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Pluristem's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Pluristem's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Pluristem's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Pluristem and how it compares across the competition.
About Pluristem Valuation
The delisted stock valuation mechanism determines the current worth of Pluristem on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Pluristem. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Pluristem based exclusively on its fundamental and basic technical indicators. By analyzing Pluristem's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Pluristem's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Pluristem. We calculate exposure to Pluristem's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Pluristem's related companies.Pluristem Therapeutics Inc. operates as a bio-technology company. Pluristem Therapeutics Inc. was incorporated in 2001 and is based in Haifa, Israel. Pluristem Therapeutics operates under Biotechnology classification in the United States and is traded on NGM Exchange. It employs 153 people.
8 Steps to conduct Pluristem's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Pluristem's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Pluristem's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Pluristem's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Pluristem's revenue streams: Identify Pluristem's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Pluristem's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Pluristem's growth potential: Evaluate Pluristem's management, business model, and growth potential.
- Determine Pluristem's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Pluristem's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Pluristem Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Pluristem does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Shares Percent Shares Out | 1.21% | |
| Forward Price Earnings | -0.80 | |
| Float Shares | 27.59M | |
| Shares Short Prior Month | 487.29k |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in Pluristem Stock
If you are still planning to invest in Pluristem check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pluristem's history and understand the potential risks before investing.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Stocks Directory Find actively traded stocks across global markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |